A NEW GENERATION OF TREATMENTS FOR A NEW ERA OF MENTAL HEALTH
Illumind Therapeutics innovates to overcome post-traumatic stress
Reconnecting science to mind
At Illumind Therapeutics, we develop treatments for neuropsychiatric disorders based on a novel and bold neurobiological model. By combining scientific rigor, conceptual innovation, and clinical insight, we are shaping the therapies of tomorrow, today.
Illumind Therapeutics is a Quebec-based neuroscience company developing new approaches to better understand and treat post-traumatic stress. Building on more than a decade of research, it is now initiating clinical studies based on an innovative scientific model of mental illness. Illumind Therapeutics collaborates with strategic partners committed to advancing current standards in mental health.
Reviving mental health through research, resilience and a desire for profound transformation
More than a treatment. A vision. A light. An Illumind signature.
Our Mission
Transforming the management of trauma-related neuropsychiatric disorders
Our approach
Combining scientific rigor, conceptual boldness and clinical sense to target specific biological roots
Our values
Strong commitments that offer next-generation therapeutic solutions to redefine current standards of mental health
“Mental health deserves better than symptomatic solutions. After more than a decade of research, we have developed a new clinical model of anxiety disorders based on deep neurobiological mechanisms, particularly those related to the modulation of glutamate and GABA. This approach paves the way for more targeted, sustainable, and truly transformative therapeutic strategies. We believe it is time to rewrite the foundations of mental health treatment.”
Dr. David Levi, Medical Director, Illumind Therapeutics
Contact
Interested in our advances in anxiety disorder treatments?
Contact our team of experts to explore collaborations and clinical trials